In 2011, the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association published an evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis (IPF). Since that time, a tremendous amount of new data on IPF treatment has accumulated, including phase III clinical trial results and newly available medications. The societies felt it was time to update the guideline focusing on IPF treatment.
- 0.50 ANCC
- 0.50 Attendance
One-time registration with AKH CME required.